Table 1 Characteristics of the CRC patients included in cfPANC754 detection of this study.

From: M6A-METTL3-dependent nuclear PANC754/PSPC1/H3K4me1 repression complex regulate immune evasive LGALS7 signal to enhance immunotherapy against colorectal cancer

Characteristics

Patient

cfPANC754 level

P value

(N = 75)

High

Low

Agea

 ≥60

57

12

45

 

 <60

18

3

15

0.685

Gender

 Male

41

9

32

 

 Female

34

6

28

0.643

Subtype

 Colon

35

5

30

 

 Rectal

32

7

25

0.418

 Unknown

8

3

5

 

Tumor size

 ≤4 cm

37

8

29

 

 >4 cm

32

5

27

0.525

 Unknown

6

2

4

 

Tumor invasionb

 T1 + T2

21

5

16

 

 T3 + T4

43

8

35

0.627

 Tx

11

2

9

 

Lymph nodeb

 N0

60

9

51

 

 ≥N1

9

4

5

0.035*

 Nx

6

2

4

 

Distant metastasisb

 M0

61

10

51

 

 M1

14

5

9

0.103

UICC Stagec

 I + II

55

8

47

 

 III + IV

20

7

13

0.050*

Tumor differentia

 High

9

2

7

 

 Medium

53

8

45

0.591

 Low

5

1

4

 

 Undefined

8

4

4

 
  1. aAge stratification was done as previously described. (Colorectal cancer statistics, 2020. CA Cancer J Clin, 2020).
  2. bTNM Stages were assessed in accordance with definitions found in the seventh edition of the TNM classification criteria.
  3. cUICC Stage: the tumor classification criteria from the Union for International Cancer Control.
  4. Bold values are used to highlight key data with statistical significance.
  5. *P < 0.05.
Back to article page